Ausgabe 4/2001
Inhalt (13 Artikel)
Compatibility and Stability of the Investigational Polypeptide Marine Anticancer Agent Kahalalide F in Infusion Devices
Bastiaan Nuijen, Marjan Bouma, Consuelo Manada, José M. Jimeno, Luis L. Lazaro, Auke Bult, Jos H. Beijnen
Changes in Prostate-Specific Antigen (PSA) Level Correlate with Growth Inhibition of Prostate Cancer Cells Treated in Vitro with a Novel Anticancer Drug, Irofulven
Barbara A. Woynarowska, Arlene L. Higdon, Ruben M. Muñoz, Perry Bushong, Stephen J. Waters
Gene Expression Profiling of Exposure to TZT-1027, a Novel Microtubule-Interfering Agent, in Non-Small Cell Lung Cancer PC-14 Cells and Astrocytes
Tsugitaka Natsume, Takashi Nakamura, Yasuhiro Koh, Motohiro Kobayashi, Nagahiro Saijo, Kazuto Nishio
A Phase I Trial of the Oral Platinum Analogue JM216 with Concomitant Radiotherapy in Advanced Malignancies of the Chest
Christopher M. George, Dan J. Haraf, Ann M. Mauer, Stuart A. Krauss, Philip C. Hoffman, Charles M. Rudin, Livia Szeto, Everett E. Vokes
Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study
Wolfram E. Samlowski, Holly Gundacker, J. Philip Kuebler, Jeffrey K. Giguere, Glenn M. Mills, David E. Schuller, John F. Ensley
Phase II Trial of Irofulven (6-Hydroxymethylacylfulvene) for Patients with Advanced Renal Cell Carcinoma
William J. Berg, Lawrence Schwartz, Richard Yu, Madhu Mazumdar, Robert J. Motzer
Phase II Trial of 9-Aminocamptothecin as a 72-h Infusion in Cutaneous T-Cell Lymphoma
Athanassios Argiris, Peter Heald, Timothy Kuzel, Francine M. Foss, Susan DiStasio, Dennis L. Cooper, Susan Arbuck, John R. Murren
Phase II Study of Pyrazoloacridine in Metastatic Renal Cell Carcinoma
J. Philip Kuebler, Gerald W. King, Pierre Triozzi, Timothy Moore, Eric H. Kraut
A Phase II Trial of 9-Aminocaptothecin (9-AC) as a 120-h Infusion in Patients with Non-Small Cell Lung Cancer
Everett E. Vokes, Gary S. Gordon, Charles M. Rudin, Ann M. Mauer, Sylvia Watson, Stuart Krauss, Rose Arrieta, Harvey M. Golomb, Philip C. Hoffman
Dolastatin-10 in Metastatic Melanoma: A Phase II and Pharmokinetic Trial of the California Cancer Consortium
Kim Margolin, Jeffrey Longmate, Timothy W. Synold, David R. Gandara, Jeffrey Weber, Rene Gonzalez, Mary J. Johansen, Robert Newman, Tracey Baratta, James H. Doroshow
Therapeutic Response to Octreotide in Patients with Refractory CPT-11 Induced Diarrhea
Barbara Pro, Richard Lozano, Jaffer A. Ajani